These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19562688)

  • 1. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury.
    Qin HD; Huang D; Weng XD; Xu F
    J Cell Physiol; 2009 Nov; 221(2):387-93. PubMed ID: 19562688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor alpha and gamma ligands differentially affect smooth muscle cell proliferation and migration.
    Zahradka P; Wright B; Fuerst M; Yurkova N; Molnar K; Taylor CG
    J Pharmacol Exp Ther; 2006 May; 317(2):651-9. PubMed ID: 16407462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
    Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
    Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
    Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.
    Yang YB; Yang YX; Su B; Tang YL; Zhu BY; Hu ZW; Li GY; Li YJ; Liao DF
    Eur J Pharmacol; 2007 Sep; 570(1-3):125-34. PubMed ID: 17628533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
    Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
    Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production.
    Hwang J; Kleinhenz DJ; Lassègue B; Griendling KK; Dikalov S; Hart CM
    Am J Physiol Cell Physiol; 2005 Apr; 288(4):C899-905. PubMed ID: 15590897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE PPARgamma ligand 15d-PGJ2 modulates macrophage activation after injury in a murine trauma model.
    Monroy MA; Opperman KK; Pucciarelli M; Yerrum S; Berg DA; Daly JM
    Shock; 2007 Aug; 28(2):186-91. PubMed ID: 17510607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro.
    Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY
    Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
    Saha S; Li Y; Lappas G; Anand-Srivastava MB
    J Mol Cell Cardiol; 2008 Feb; 44(2):336-44. PubMed ID: 18162186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical loading and delta12prostaglandin J2 induce bone morphogenetic protein-2, peroxisome proliferator-activated receptor gamma-1, and bone nodule formation in an osteoblastic cell line.
    Siddhivarn C; Banes A; Champagne C; Riché EL; Weerapradist W; Offenbacher S
    J Periodontal Res; 2007 Oct; 42(5):383-92. PubMed ID: 17760815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells.
    Bernardo A; Bianchi D; Magnaghi V; Minghetti L
    J Neuropathol Exp Neurol; 2009 Jul; 68(7):797-808. PubMed ID: 19535992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of late lumen loss after antiproliferative percutaneous coronary intervention using beta-irradiation in a porcine model of restenosis.
    Deiner C; Loddenkemper C; Rauch U; Rosenthal P; Pauschinger M; Schwimmbeck PL; Schultheiss HP; Pels K
    Cardiovasc Revasc Med; 2007; 8(2):94-8. PubMed ID: 17574167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 15-Deoxy-Δ-
    Eguez C; Clark MA; O'Connor AT
    Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106583. PubMed ID: 34332056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.
    Nakamura K; Yamagishi S; Matsui T; Yoshida T; Takenaka K; Jinnouchi Y; Yoshida Y; Ueda S; Adachi H; Imaizumi T
    Am J Pathol; 2007 Jun; 170(6):2159-70. PubMed ID: 17525281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.